What is JP Morgan saying about the Telstra (ASX:TLS) share price?

JP Morgan gives its take on the telecommunications' company share price.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in telecommunications giant Telstra Corporation Ltd (ASX: TLS) are inching higher in afternoon trade and are changing hands at $3.97 apiece.

Telstra's share price bounced off a low of $3.73 on 22 October with authority and are now up 3% for the month. For reference, the benchmark S&P/ASX 200 Index (ASX: XJO) has climbed 0.1% in that time.

Whilst there's been no price-sensitive information for the company today, analysts at JP Morgan released a note to clients indicating its outlook for the Telstra share price.

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.

Image source: Getty Images

What did JP Morgan say?

JP Morgan reckons that Telstra's drive to be one of Australia's top energy retailers by FY25 isn't as appealing as it might sound.

The broker thinks Telstra's plan is lacking in a few key areas, especially given the markets for household data and energy provision. It states the returns would capture a small percentage of market share, and would only contribute a little over 3% of Telstra's annual earnings before interest and tax (EBIT).

Nonetheless, in another report released in late October, JP Morgan labels Telstra as "the best placed in the Australian mobile market" that is early to the game and well diversified.

And even in view of the commentary, it retained its overweight rating on the share in the note today.

For instance, it said the company's "headstart on the rollout of 5G infrastructure should see market share gains of lucrative postpaid subscribers".

Aside from this, the broker was pleased with Telstra's acquisition of Pacific telecom provider Digicel. It notes the deal is likely to add another annual EBITDA of $310 million to the company.

It now estimates an FY22 underlying EBITDA of $7.2 billion for Telstra, which is still within the company guidance of $7 billion to $7.3 billion.

Telstra's share price was well below JP Morgan's price target of $4.60 at the time, which still implies an upside potential of around 16% at the time of writing.

What are other brokers saying?

Analysts at HSBC also have a $5.20 price target on the share whereas Jefferies has a buy rating and $4.60 valuation as well.

And as The Motley Fool reported earlier today, the team at Morgans also have a buy rating and likes Telstra's upcoming dividend of 16 cents per share.

In fact, of the 14 analysts or firms covering Telstra identified, 64% have a buy recommendation and bullish direction on their price targets. Hence, JP Morgan is aligned with that sentiment.

Telstra share price last 12 months

In the last 12 months, the Telstra share price has gained 27% after rallying another 33% this year to date. Both of these returns have far outpaced the broad indices.

It has been a fairly smooth run for Telstra shareholders in that time, having really come off a low of $3.06 on 7 May.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »